Wolfenbuttel, Germany

Michael Morr


Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 54(Granted Patents)


Location History:

  • Brunswick, DE (1982)
  • Braunschweig, DE (1983)
  • Wolfenbuttel, DE (1987 - 2008)

Company Filing History:


Years Active: 1982-2008

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Michael Morr: Innovator in Biotechnological Research

Introduction

Michael Morr is a distinguished inventor based in Wolfenbuttel, Germany. He has made significant contributions to the field of biotechnology, holding a total of seven patents. His work focuses on innovative solutions that enhance biological processes and therapeutic applications.

Latest Patents

Among his latest patents is the invention titled "Bisacyloxypropylcysteine conjugates and the use thereof." This invention provides lipopeptide conjugates where a cysteine, double-substituted by a fatty acid, is bonded through the carboxyl group to a highly soluble, physiologically compatible, and non-immunogenic polymeric conjugate group. These conjugates exhibit excellent macrophage stimulant action and do not require additional solubilizing agents. They have a wide range of applications, particularly in stimulating macrophages, antibody synthesis, combating infections, and serving as immunostimulants, especially in relation to tumors. They can also be used for preventing and treating septic shock, wound healing, and as adjuvants for vaccines. Another notable patent involves "Compounds having side chains with multiple methyl branches and their use," which includes compounds with specific structural formulas that enhance their efficacy.

Career Highlights

Michael Morr has worked with notable organizations, including Gesellschaft für Biotechnologische Forschung mbH, where he contributed to various research initiatives. His expertise in biotechnology has allowed him to develop innovative solutions that address complex biological challenges.

Collaborations

Throughout his career, Michael has collaborated with esteemed colleagues such as Maria-Regina Kula and Christel Kakoschke. These partnerships have fostered a collaborative environment that promotes innovation and research advancement.

Conclusion

Michael Morr's contributions to biotechnology through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence therapeutic applications and enhance our understanding of biological processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…